Insider trades
Andrew Reardon, CLO of Ligand Pharmaceuticals LGND, has filed 0 purchases and 38 sales on the open market. Over the past 12 months that comes to a net sale of $4.3M. The latest trade was on 06/01.
Andrew Reardon
CLO & Secretary
- Company
- Ligand Pharmaceuticals LGND
- First filing
- 23/02/27
- Trades
- 80 trades
- Buys / sales
- 0 / 38
- 12-month net buying
- −$4.3M
- Last trade
- 06/01
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
LGND | Open-market sale10b5-1 plan | 06/01 | 06/02 | 5,000 sh7 trades | $227.06avg. | $1,135,323.29 | −10.8% |
LGND | Open-market sale10b5-1 plan | 05/01 | 05/04 | 5,000 sh7 trades | $231.31avg. | $1,156,552.08 | −10.8% |
LGND | Open-market sale10b5-1 plan | 04/01 | 04/02 | 5,000 sh6 trades | $201.24avg. | $1,006,217.52 | −10.8% |
LGND | Open-market sale10b5-1 plan | 03/04 | 03/06 | 5,000 sh11 trades | $206.35avg. | $1,031,774.16 | −11.9% |
| Open-market sale | 25/06/23 | 25/06/24 | 500 sh | $114.08 | $57,040 | −1.5% | |
| Open-market sale | 25/06/10 | 25/06/12 | 500 sh | $114.54 | $57,270 | −1.5% | |
| Open-market sale | 25/05/15 | 25/06/02 | 1,000 sh | $104.00 | $104,000 | −2.9% | |
| Open-market sale | 24/09/23 | 24/09/25 | 2,000 sh | $99.60 | $199,200 | −8.2% | |
| Open-market sale | 24/08/28 | 24/08/30 | 1,500 sh | $106.39 | $159,585 | −6.2% | |
| Open-market sale | 24/05/09 | 24/05/13 | 10,000 sh | $83.04 | $830,400 | −31.1% | |
| Open-market sale | 23/03/24 | 23/03/28 | 300 sh | $69.92 | $20,976 | −1.8% |